Clinical Trial

Safety and Efficacy of PSMA-Targeted Fluorescent Contrast Agent DGPR1008 for Intraoperative Imaging in Robot-Assisted Radical Prostatectomy

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated February 17, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study is a single-center, single-arm, open-label exploratory study to evaluate the safety and efficacy of fluorescent imaging combined with a robotic surgical control system for robot-assisted radical prostatectomy.
Trial Details
NCT Number NCT07415135
Lead Sponsor Zhu Yinjie
Conditions Prostate Cancer
Enrollment 18 participants
Start Date 2026-03-01
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-17